Protein Description

Gene Symbol RASA1
Entrez ID 5921
Uniprot ID P20936
Description RAS p21 protein activator (GTPase activating protein) 1
Chromosomal Location chr5: 87,267,888-87,391,931
Ontology GO ID GO Term Definition Evidence

BP

GO:0000165

MAPK cascade

An intracellular protein kinase cascade containing at least a MAPK, a MAPKK and a MAP3K. The cascade can also contain two additional tiers: the upstream MAP4K and the downstream MAP Kinase-activated kinase (MAPKAPK). The kinases in each tier phosphorylate and activate the kinases in the downstream tier to transmit a signal within a cell.

TAS

BP

GO:0000281

mitotic cytokinesis

A cell cycle process that results in the division of the cytoplasm of a cell after mitosis, resulting in the separation of the original cell into two daughter cells.

ISS

BP

GO:0001570

vasculogenesis

The differentiation of endothelial cells from progenitor cells during blood vessel development, and the de novo formation of blood vessels and tubes.

ISS

BP

GO:0001953

negative regulation of cell-matrix adhesion

Any process that stops, prevents, or reduces the rate or extent of cell adhesion to the extracellular matrix.

IDA

BP

GO:0007162

negative regulation of cell adhesion

Any process that stops, prevents, or reduces the frequency, rate or extent of cell adhesion.

IDA

BP

GO:0007165

signal transduction

The cellular process in which a signal is conveyed to trigger a change in the activity or state of a cell. Signal transduction begins with reception of a signal (e.g. a ligand binding to a receptor or receptor activation by a stimulus such as light), or for signal transduction in the absence of ligand, signal-withdrawal or the activity of a constitutively active receptor. Signal transduction ends with regulation of a downstream cellular process, e.g. regulation of transcription or regulation of a metabolic process. Signal transduction covers signaling from receptors located on the surface of the cell and signaling via molecules located within the cell. For signaling between cells, signal transduction is restricted to events at and within the receiving cell.

IDA

BP

GO:0008360

regulation of cell shape

Any process that modulates the surface configuration of a cell.

NAS

BP

GO:0009790

embryo development

The process whose specific outcome is the progression of an embryo from its formation until the end of its embryonic life stage. The end of the embryonic stage is organism-specific. For example, for mammals, the process would begin with zygote formation and end with birth. For insects, the process would begin at zygote formation and end with larval hatching. For plant zygotic embryos, this would be from zygote formation to the end of seed dormancy. For plant vegetative embryos, this would be from the initial determination of the cell or group of cells to form an embryo until the point when the embryo becomes independent of the parent plant.

ISS

BP

GO:0030833

regulation of actin filament polymerization

Any process that modulates the frequency, rate or extent of the assembly of actin filaments by the addition of actin monomers to a filament.

IDA

BP

GO:0035556

intracellular signal transduction

The process in which a signal is passed on to downstream components within the cell, which become activated themselves to further propagate the signal and finally trigger a change in the function or state of the cell.

NAS

BP

GO:0043524

negative regulation of neuron apoptotic process

Any process that stops, prevents, or reduces the frequency, rate or extent of cell death by apoptotic process in neurons.

ISS

BP

GO:0043547

positive regulation of GTPase activity

Any process that activates or increases the activity of a GTPase.

IEA

BP

GO:0046580

negative regulation of Ras protein signal transduction

Any process that stops, prevents, or reduces the frequency, rate or extent of Ras protein signal transduction.

IBA

BP

GO:0048013

ephrin receptor signaling pathway

The series of molecular signals generated as a consequence of an ephrin receptor binding to an ephrin.

TAS

BP

GO:0048514

blood vessel morphogenesis

The process in which the anatomical structures of blood vessels are generated and organized. The blood vessel is the vasculature carrying blood.

IMP

BP

GO:0051252

regulation of RNA metabolic process

Any process that modulates the frequency, rate or extent of the chemical reactions and pathways involving RNA.

NAS

CC

GO:0001726

ruffle

Projection at the leading edge of a crawling cell; the protrusions are supported by a microfilament meshwork.

IEA

CC

GO:0005737

cytoplasm

All of the contents of a cell excluding the plasma membrane and nucleus, but including other subcellular structures.

IBA|NAS

CC

GO:0005829

cytosol

The part of the cytoplasm that does not contain organelles but which does contain other particulate matter, such as protein complexes.

TAS

CC

GO:0031235

intrinsic component of the cytoplasmic side of the plasma membrane

The component of a plasma membrane consisting of gene products and protein complexes that have some covalently attached part (e.g. peptide sequence or GPI anchor) which is embedded in the cytoplasmic side of the plasma membrane only.

IBA

MF

GO:0001948

glycoprotein binding

Interacting selectively and non-covalently with a glycoprotein, a protein that contains covalently bound glycose (monosaccharide) residues. These also include proteoglycans.

IPI

MF

GO:0005096

GTPase activator activity

Binds to and increases the activity of a GTPase, an enzyme that catalyzes the hydrolysis of GTP.

EXP

MF

GO:0005102

receptor binding

Interacting selectively and non-covalently with one or more specific sites on a receptor molecule, a macromolecule that undergoes combination with a hormone, neurotransmitter, drug or intracellular messenger to initiate a change in cell function.

IPI

MF

GO:0005515

protein binding

Interacting selectively and non-covalently with any protein or protein complex (a complex of two or more proteins that may include other nonprotein molecules).

IPI

MF

GO:0019870

potassium channel inhibitor activity

Stops, prevents, or reduces the activity of a potassium channel.

NAS

MF

GO:0051020

GTPase binding

Interacting selectively and non-covalently with a GTPase, any enzyme that catalyzes the hydrolysis of GTP.

IPI

Domain ID Description

IPR000008

C2 domain

IPR000980

SH2 domain

IPR001452

SH3 domain

IPR001849

Pleckstrin homology domain

IPR001936

Ras GTPase-activating protein

IPR008936

Rho GTPase activation protein

IPR011993

PH domain-like

IPR023152

Ras GTPase-activating protein, conserved site

IPR028554

Ras GTPase-activating protein 1

Pathway ID Pathway Term Pathway Source

hsa04010

MAPK signaling pathway

KEGG

hsa04014

Ras signaling pathway

KEGG

hsa04360

Axon guidance

KEGG

WP437

EGF/EGFR Signaling Pathway

WikiPathways

WP313

Signaling of Hepatocyte Growth Factor Receptor

WikiPathways

WP3303

Rac1/Pak1/p38/MMP-2 pathway

WikiPathways

WP2526

PDGF Pathway

WikiPathways

WP382

MAPK Signaling Pathway

WikiPathways

WP2583

T-Cell Receptor and Co-stimulatory Signaling

WikiPathways

WP581

EPO Receptor Signaling

WikiPathways

h_egfPathway

EGF Signaling Pathway

BioCarta

h_HivnefPathway

HIV-I Nef: negative effector of Fas and TNF

BioCarta

h_igf1Pathway

IGF-1 Signaling Pathway

BioCarta

h_insulinPathway

Insulin Signaling Pathway

BioCarta

h_pdgfPathway

PDGF Signaling Pathway

BioCarta

h_sam68Pathway

Regulation of Splicing through Sam68

BioCarta

h_metPathway

Signaling of Hepatocyte Growth Factor Receptor

BioCarta

h_spryPathway

Sprouty regulation of tyrosine kinase signals

BioCarta

h_tcrPathway

T Cell Receptor Signaling Pathway

BioCarta

h_TPOPathway

TPO Signaling Pathway

BioCarta

UMLS CUI UMLS Term

C0003857

Congenital Arteriovenous Malformation

C0007117

Basal Cell Carcinoma

C0017661

Iga Glomerulonephritis

C0024667

Animal Mammary Neoplasms

C0024668

Mammary Neoplasms, Experimental

C0038505

Sturge-Weber Syndrome

C0235752

Port-Wine Stain

Tissue Cell Type

placenta

trophoblastic cells

Database Name

DGA

Pubmed ID Author Year Title

17148555

Wood et al.

2007

Molecular Abnormalities in Oocytes from Women with Polycystic Ovary Syndrome Revealed by Microarray Analysis

Gene Symbol Entrez ID Uniprot ID Score

RET

5979

P07949

0.00

RRAS

6237

P10301

0.00

RRAS2

22800

P62070

0.00

DCC

1630

P43146

0.49

STK11

6794

Q15831

0.49

BCL10

8915

O95999

0.49

EPHA2

1969

P29317

0.52

HSPD1

3329

P10809

0.52

LYN

4067

P07948

0.52

SYK

6850

P43405

0.52

SHC1

6464

P29353

0.55

APP

351

P05067

0.56

ERBB3

2065

P21860

0.63

ERBB4

2066

Q15303

0.63

EZH2

2146

Q15910

0.63

FLNB

2317

O75369

0.63

FLNC

2318

Q14315

0.63

XRCC6

2547

P12956

0.63

SERPINA4

5267

P29622

0.63

SDC2

6383

P34741

0.63

SOCS1

8651

O15524

0.63

EIF1

10209

P41567

0.63

TRMT2A

27037

Q8IZ69

0.63

PLEKHH1

57475

Q9ULM0

0.63

BBS10

79738

Q8TAM1

0.63

OLIG1

116448

Q8TAK6

0.63

ZNF579

163033

Q8NAF0

0.63

RASA1

5921

P20936

0.65

SPSB1

80176

Q96BD6

0.67

CAPNS1

826

P04632

0.72

ERBB2

2064

P04626

0.73

CSK

1445

P41240

0.75

KIT

3815

P10721

0.83

GRB2

2885

P62993

0.84

DLC1

10395

Q96QB1

0.87

CAV2

858

P51636

0.88

ANXA6

309

P08133

0.95

CD79B

974

P40259

0.00

EGF

1950

P01133

0.00

EPHA1

2041

P21709

0.00

EPHA5

2044

P54756

0.00

EPHB1

2047

P54762

0.00

EPHB4

2050

P54760

0.00

EPHB6

2051

O15197

0.00

FLT1

2321

P17948

0.00

KRAS

3845

P01116

0.00

PDGFA

5154

P04085

0.00

RAF1

5894

P04049

0.00

MRAS

22808

O14807

0.00

EPHA6

285220

Q9UF33

0.00

ALK

238

Q9UM73

0.49

APC

324

P25054

0.49

BMPR1A

657

P36894

0.49

BUB1

699

O43683

0.49

CDKN2A

1029

Q8N726

0.49

FYN

2534

P06241

0.49

SMAD2

4087

Q15796

0.49

NRAS

4893

P01111

0.49

PMS2

5395

P54278

0.49

PTPRJ

5795

Q12913

0.49

RB1

5925

P06400

0.49

AURKA

6790

O14965

0.49

ATF7

11016

P17544

0.49

MLH3

27030

Q9UHC1

0.49

BIRC5

332

O15392

0.52

BCR

613

P11274

0.52

CASP3

836

P42574

0.52

CASP7

840

P55210

0.52

CSF1R

1436

P07333

0.52

RAB5A

5868

P20339

0.52

RAP1A

5906

P62834

0.52

STAU1

6780

O95793

0.52

MAGI1

9223

Q96QZ7

0.52

WWP1

11059

Q9H0M0

0.52

WWP2

11060

O00308

0.52

DOK4

55715

Q8TEW6

0.55

AFAP1L2

84632

Q8N4X5

0.55

CAV1

857

Q03135

0.56

FYB

2533

O15117

0.56

ABI1

10006

Q8IZP0

0.58

ARHGAP5

394

Q13017

0.59

ARHGAP1

392

Q07960

0.62

PIK3R1

5295

P27986

0.62

TSC1

7248

Q92574

0.63

FES

2242

P07332

0.65

AURKB

9212

Q96GD4

0.65

AR

367

P10275

0.72

MET

4233

P08581

0.72

KDR

3791

P35968

0.73

SYN1

6853

P17600

0.73

YES1

7525

P07947

0.73

MAP4K4

9448

O95819

0.73

ABL1

25

P00519

0.75

CD5

921

P06127

0.75

PDE6D

5147

O43924

0.75

SLC9A2

6549

Q9UBY0

0.75

NTRK1

4914

P04629

0.77

EPHB3

2049

P54753

0.79

ARHGAP35

2909

Q9NRY4

0.79

IGF1R

3480

P08069

0.79

LCK

3932

P06239

0.79

SOCS3

9021

O14543

0.79

PXN

5829

P49023

0.83

ZAP70

7535

P43403

0.83

G3BP1

10146

Q13283

0.84

PLCG1

5335

P19174

0.85

GAB1

2549

Q13480

0.86

INSR

3643

P06213

0.86

EPHB2

2048

P29323

0.88

HCK

3055

P08631

0.88

HTT

3064

P42858

0.88

PDGFRB

5159

P09619

0.88

SRC

6714

P12931

0.88

RACK1

10399

P63244

0.88

EGFR

1956

P00533

0.89

PTK2B

2185

Q14289

0.89

DNAJA3

9093

Q96EY1

0.89

NCK1

4690

P16333

0.90

KHDRBS1

10657

Q07666

0.90

DOK2

9046

O60496

0.92

DOK1

1796

Q99704

0.95

HRAS

3265

P01112

0.97